News

The contract provides Novo Nordisk with the opportunity to supply human insulin NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), and

Intercell has posted a net income of EUR7.5m, compared to EUR30.96m for the comparable period in 2008. For the full year ended December 31, 2009, the company has

Reportedly, Pluristem is expected to involve 15 adults in the study. The Phase I study is designed to evaluate the safety of PLX-PAD on three dose levels in

The acquisition brings together two ISO-certified suppliers of rigid packaging products and services. The combined company will have over 40 sales and warehouse locations across the US and

The trial is expected to evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration and polymerase inhibitors ABT-333 and ABT-072 currently

Stirling said that the facility has been purchased on terms at a major discount to the going-concern replacement value (estimated by the company to be in excess of

Alda said that the divisional patent includes claims to additional aspects of the T36 formulation, including the use of T36 as a component of a personal lubricant, in

As previously announced, in October 2009, Impax has reached agreement with Astellas Pharma and Boehringer Ingelheim Pharmaceuticals to settle US patent litigation related to its ANDA for its

The patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal